Molecular mechanisms by which dietary isoflavones potentially prevent atherosclerosis.
Dietary isoflavones are currently receiving much attention because of their potential role in preventing coronary artery disease and other chronic diseases. Accumulating evidence from cell culture and laboratory animal experiments indicates that isoflavones have the potential to prevent or delay atherogenesis. Suggested mechanisms of action include: a reduction in low-density lipoprotein (LDL) cholesterol and a potential reduction in the susceptibility of the LDL particle to oxidation; (2) an improvement in vascular reactivity; (3) an inhibition of pro-inflammatory cytokines, cell adhesion proteins and nitric oxide (NO) production; and (4) an inhibition of platelet aggregation. These mechanisms are consistent with the epidemiological evidence that a high consumption of isoflavone-rich soy products is associated with a reduced incidence of coronary artery disease. Biological effects of isoflavones are dependent on many factors, including dose consumed, duration of use, protein-binding affinity, and an individual's metabolism or intrinsic oestrogenic state. Further clinical studies are necessary to determine the potential health effects of isoflavones in specific population groups as we currently know little about age-related differences in exposure to these compounds and there are few guidelines on optimal dose for cardiovascular health benefits.
Hugh Sinclair Human Nutrition Unit, School of Food Biosciences, University of Reading, Whiteknights, Reading, RG6 6AP, UK. cassidyaedin@hotmail.com
Aedin
A
Cassidy
Sonia
S
de Pascual Teresa
Gerald
G
Rimbach
D000818:Animals; D050197:Atherosclerosis / Q000235:genetics* / Q000517:prevention & control*; D003327:Coronary Disease / Q000517:prevention & control*; D004032:Diet; D005260:Female; D006801:Humans; D007529:Isoflavones / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008055:Lipids / Q000502:physiology; D008297:Male; D048789:Phytoestrogens / Q000627:therapeutic use; D011960:Receptors, Estrogen / Q000032:analysis; D014018:Tissue Distribution
D007529:Isoflavones; D008055:Lipids; D048789:Phytoestrogens; D011960:Receptors, Estrogen